The SDF-1/CXCR4 ligand/receptor pair is an important contributor to several types of ocular neovascularization

FASEB Journal

Volumn 21, Issue 12, 2007, Pages 3219-3230

  Lima E Silva, Raquel ^a   Shen, Jikui ^a   Hackett, Sean F ^a   Kachi, Shu ^a   Akiyama, Hideo ^a   Kiuchi, Katsuji ^a   Yokoi, Katsutoshi ^a   Hatara, Maria C ^a   Lauer, Thomas ^a   Aslam, Sadia ^a   Gong, Yuan Yuan ^a   Xiao, Wei Hong ^a   Khu, Naw Htee ^a   Thut, Catherine ^b   Campochiaro, Peter A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Age related macular degeneration; Angiogenesis; Chemokines; Diabetic retinopathy; Inflammation

Indexed keywords

1 PYRIDIN 2 YL N [4 (1,4,7 TRIAZACYCLOTETRADECAN 4 YLMETHYL)BENZYL]METHANAMINE; AMD 8664; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; MESSENGER RNA; N (1 METHYL 1 PHENYLETHYL) N [[1 [2 [5 (4H 1,2,4 TRIAZOL 4 YL) 1H INDOL 3 YL]ETHYL]PYRROLIDIN 3 YL]METHYL]AMINE; STROMAL CELL DERIVED FACTOR 1; TC 14012; UNCLASSIFIED DRUG; VASCULOTROPIN; 1 PYRIDIN 2 YL N (4 (1,4,7 TRIAZACYCLOTETRADECAN 4 YLMETHYL)BENZYL)METHANAMINE; 1-PYRIDIN-2-YL-N-(4-(1,4,7-TRIAZACYCLOTETRADECAN-4-YLMETHYL)BENZYL)METHANAMINE; CD31 ANTIGEN; CD45 ANTIGEN; CXCL12 PROTEIN, MOUSE; CXCR4 PROTEIN, MOUSE; DIFFERENTIATION ANTIGEN; MONOCYTE MACROPHAGE DIFFERENTIATION ANTIGEN; MONOCYTE-MACROPHAGE DIFFERENTIATION ANTIGEN; OLIGOPEPTIDE; PTPRC PROTEIN, MOUSE; PYRIDINE DERIVATIVE; TC14012; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOCRINE EFFECT; BONE MARROW CELL; CELL TYPE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DNA RESPONSIVE ELEMENT; GLIA CELL; HEART MUSCLE ISCHEMIA; HYPOXIA; INFLAMMATION; LIVER ISCHEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETINA; RETINA MACULA AGE RELATED DEGENERATION; RETINA NEOVASCULARIZATION; UPREGULATION; ANIMAL; ANOXIA; C57BL MOUSE; CORNEA NEOVASCULARIZATION; DRUG ANTAGONISM; GENETICS; HISTOLOGY; HUMAN; ISCHEMIA; METABOLISM; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; ANOXIA; ANTIGENS, CD31; ANTIGENS, CD45; ANTIGENS, DIFFERENTIATION; BONE MARROW CELLS; CHEMOKINE CXCL12; CORNEAL NEOVASCULARIZATION; HUMANS; ISCHEMIA; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OLIGOPEPTIDES; PYRIDINES; RECEPTORS, CXCR4; RETINA; RETINAL NEOVASCULARIZATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 35248894453     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.06-7359com     Document Type: Article

References (50)

1. Mackay, C. R. (2001) Chemokines: immunology's high impact factors. Nat. Immunol. 2, 95-101
2. Balabanian, K., Lagane, B., Infantino, S., Chow, K. Y., Harriague, J., Moepps, B., Arenzana-Seisdedos, F., Thelen, M., and Bachelerie, F. (2005) The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J. Biol. Chem. 280, 35760-35766
3. Federsppiel, B., Melhado, I. G., Duncan, A. M., Delaney, A., Schappert, K., Clark-Lewis, K., and Jink, F. R. (1993) Molecular cloning of the cDNA and chromosomal localization of the gene for a putative seven-transmembrane segment (7-TMS) receptor isolated from human spleen. Genomics 16, 707-712
4. Nomura, H., Nielsen, B. W., and Matsushima, K. (1993) Molecular cloning of cDNAs encoding a LD78 receptor and putative leukocyte chemotactic peptide receptors. Int. Immunol. 5, 1239-1249
5. Loetscher, M. Geiser, T., O'Reilly, T., Zwahlen, R., Baggiolini, M., and Moser, B. (1994) Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. J. Biol. Chem. 269, 232-237
6. Feng, Y., Broder, C. C., Kennedy, P. E., and Berger, E. A. (1996) HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872-877
7. Deng, C. X., Wynshaw, B. A., Shen, M. M., Daugherty, C., Ornitz, D. M., and Leder, P. (1994) Murine FGFR-1 is required for early postimplantation growth and axial organization. Genes Dev. 8, 3045-3057
8. Doranz, B. J., Rucker, J., Yi, Y., Smyth, R. J., Samson, M., Peiper, S. C., Parmentier, M., Collman, R. G., and Doms, R. W. (1996) A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR2b as fusion cofactors. Cell 85, 1149-1158
9. Bleul, C. C., Farzan, M., Choe, H., Parolin, C., Clark-Lewis, I., Sodroski, J., and Springer, T. A. (1996) The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382, 829-833
10. Oberlin, E., Amara, A., Bachelerie, F., Bessia, C., Virelizier, J. L., Arenzana-Seisdedos, F., Schwartz, O., Heard, J. M., Clark-Lewis, I., Legler, D. F., Loetscher, M., Baggiolini, M., and Moser, B. (1996) The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382
11. Bleul, C. C., Fuhlbrigge, R. C., Casasnovas, J. M., Aruti, A., and Springer, T. A. (1996) A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 184, 1101-1109
12. + progenitors to peripheral blood. J. Exp. Med. 185, 111-120
13. Jo, D. Y., Rafii, S., Hamada, T., and Moore, M. A. (2000) Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1. J. Clin. Invest. 105, 101-111
14. Jin, D. K., Shido, K., Kopp, H. G., Petit, I., Shmelkov, S. V., Yong, L. M., Hooper, A. T., Amano, H., Avecilla, S. T., Heissig, B., Hattori, K., et al. (2006) Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat. Med. 12, 557-567
15. McGrath, K. E., Koniski, A. D., Maltby, K. M., McKann, J. K., and Palis, J. (1999) Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4. Dev. Biol. 213, 442-456
16. Murdoch, C., Monk, P. N., and Finn, A. (1999) CXC chemokine receptor expression on human endothelial cells. Cytokine 11, 704-712
17. Gupta, S. K., Lysko, P. G., Pillarisetti, K., Ohlstein, E., and Stadel, J. M. (1998) Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines. J. Biol. Chem. 273, 4282-4287
18. Salcedo, R., Wasserman, K., Young, H. A., Grimm, M. C., Howard, O. M. Z., Anver, M. R., Kleinman, H. K., Murphy, W. J., and Oppenheim, J. J. (1999) Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells. In vivo neovascularization induced by stromal-derived factor-1alpha. Am. J. Pathol. 154, 1125-1135
19. Tachibana, K., Hirota, S., Iizasa, H., Yoshida, H., Kawabata, K., Kataoka, Y., Kitamura, Y., Matsushima, K., Yoshida, N., Nishikawa, S., et al. (1998) The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 393, 591-594
20. Smith, L. E. H., Wesolowski, E., McLellan, A., Kostyk, S. K., D'Amato, R., Sullivan, R., and D'Amore, P. A. (1994) Oxygen-induced retinopathy in the mouse. Invest. Ophthalmol. Vis. Sci. 35, 101-111
21. Seo, M.-S., Kwak, N., Ozaki, H., Yamada, H., Okamoto, N., Fabbro, D., Hofmann, F., Wood, J. M., and Campochiaro, P. A. (1999) Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor. Am. J. Pathol. 154, 1743-1753
22. Okamoto, N., Tobe, T., Hackett, S. F., Ozaki, H., Vinores, M. A., LaRochelle, W., Zack, D. J., and Campochiaro, P. A. (1997) Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am. J. Pathol. 151, 281-291
23. Tobe, T., Okamoto, N., Vinores, M. A., Derevjanik, N. L., Vinores, S. A., Zack, D. J., and Campochiaro, P. A. (1998) Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors. Invest. Ophthalmol. Vis. Sci. 39, 180-188
24. Ohno-Matsui, K., Hirose, A., Yamamoto, S., Saikia, J., Okamoto, N., Gehlbach, P., Duh, E. J., Hackett, S. F., Chang, M., Bok, D., et al. (2002) Inducible expression of vascular endothelial growth factor in photoreceptors of adult mice causes severe proliferative retinopathy and retinal detachment. Am. J. Pathol. 160, 711-719
25. Tobe, T., Ortega, S., Luna, J. D., Ozaki, H., Okamoto, N., Derevjanik, N. L., Vinores, S. A., Basilico, C., and Campochiaro, P. A. (1998) Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am. J. Pathol. 153, 1641-1646
26. Nambu, H., Nambu, R., Melia, M., and Campochiaro, P. A. (2003) Combretastatin A-4 phosphate suppresses development and induces regression of choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 44, 3650-3655
27. Verbeke, G., and Molenberghs, G. (2000) Linear Mixed Models for Longitudinal Data, Springer-Verlag, Inc., New York
28. Alon, T., Hemo, I., Itin, A., Pe'er, J., Stone, J., and Keshet, E. (1995) Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nature Med. 1, 1024-1028
29. Pierce, E. A., Avery, R. L., Foley, E. D., Aiello, L. P., and Smith, L. E. H. (1995) Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc. Natl. Acad. Sci. U. S. A. 92, 905-909
30. Ohno, S., Nakamura, S., Hori, S., Shimakawa, M., Kawashima, H., Mochizuki, M., Sugita, S., Ueno, S., Yoshizaki, K., and Inaba, G. (2004) Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behcet's disease with refractory uveoretinitis. J. Rheumatol. 2004, 1362-1368
31. Trowbridge, I. S., Ostergaard, H. L., and Johnson, P. (1991) CD45: a leukocyte-specific member of the protein tyrosine phosphatase family. Biochim. Biophys. Acta 1095, 46-56
32. Austyn, J. M., and Gordon, S. (1981) F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol. 11, 805-815
33. Lewis, G. P., and Fisher, S. K. (2003) Up-regulation of glial fibrillary acidic protein in response to retinal injury: its potential role in glial remodeling and a comparison to vimentin expression. Int. Rev. Cytol. 230, 263-290
34. Barleon, B., Sozzani, S., Zhou, D., Weich, H. A., Mantovani, A., and Marme, D. (1996) Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87, 3336-3343
35. Clauss, M., Weich, H., Breier, G., Knies, U., Rockl, W., Waltenberger, J., and Risau, W. (1996) The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J. Biol. Chem. 271, 17639-17634
36. Sawano, A., Iwai, S., Sakurai, Y., Ito, M., Shitara, K., Nakahata, T., and Shibuya, M. (2001) Vascular endothelial growth factor receptor-1 (Flt-1) is a novel cell surface marker for the lineage of monocyte-macrophages in human. Blood 97, 785-791
37. Ozaki, H., Seo, M.-S., Ozaki, K., Yamada, H., Yamada, E., Hofmann, F., Wood, J., and Campochiaro, P. A. (2000) Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. Am. J. Pathol. 156, 679-707
38. Kwak, N., Okamoto, N., Wood, J. M., and Campochiaro, P. A. (2000) VEGF is an important stimulator in a model of choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 41, 3158-3164
39. R1R2 suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier. J. Cell Physiol. 195, 241-248
40. Grunewald, M., Avraham, I., Dor, Y., Bachar-Lustig, E., Itin, A., Yung, S., Chimenti, S., Landsman, L., Abramaovitch, R., and Keshet, E. (2006) VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124, 175-189
41. Grant, M. B., May, W. S., Caballero, S., Brown, G. A., Guthrie, S. M., Mamee, R. N., Byrne, B. J., Vaught, T., Spoerri, P. E., Peck, A. B., and Scott, E. W. (2002) Adult hematopoietic stem cells provide functional hemangioblastic activity during retinal neovascularization. Nat. Med. 8, 607-612
42. Espinosa-Heidmann, D. G., Caicado, A., Hernandez, E. P., Csaky, K. G., and Cousins, S. W. (2003) Bone marrow-derived progenitor cells contribute to experimental choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 44, 4914-4919
43. Chan-Ling, T., Baxter, L., Afzal, A., Sengupta, N., Caballero, S., Rosinova, E., and Grant, M. B. (2006) Hematopoietic stem cells provide repair functions after laser-induced Bruch's membrane rupture model of choroidal neovascularization. Am. J. Pathol. 168, 1031-1044
44. Amoaku, W. M. K., and Archer, D. B. (1990) Cephalic radiation and retinal vasculopathy. Eye 4, 195-203
45. Klein, R. (1992) Retinopathy in a population-based study. Trans. Am. Ophthalmol. Soc. 90, 561-594
46. Klein, R., and Klein, B. (1995) Vision disorders in diabetes. In Diabetes in America (Group, N. D. D., ed) pp. 293-330, National Institutes of Health, Washington, D.C.
47. Brooks, H. L. J., Caballero, S. J., Newell, C. K., Steinmetz, R. L., Watson, D., Seqal, M. S., Harrsion, J. K., Scott, E. W., and Grant, M. B. (2004) Vitreous levels of vascular endothelial growth factor and stomal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone. Arch. Ophthalmol. 122, 1801-1807
48. Butler, J. M., Guthrie, S. M., Koc, M., Afzal, A., Caballero, S., Brooks, H. L., Mames, R. N., Seqal, M. S., Grant, M. B., and Scott, E. W. (2005) SDF-1 is both necessary and sufficient to promote proliferative retinopathy. J. Clin. Invest. 115, 86-93
49. Klein, R., Klein, B. E. K., and Linton, K. P. (1993) The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. Am. J. Epidemiol. 137, 190-200
50. Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., Kim, R. Y., and the MARINA Study Group (2006) Ranibizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 355, 1419-1431